For managed care organizations and health systems, the recommendations strongly advocated highly selective use of NGS. Routine, nonselective NGS for all sarcoma patients is not justified. Instead, ...
While next-generation sequencing (NGS) has become routine in academic settings, its use for patients with follicular lymphoma ...
Pillar Biosciences, Inc., the leader in Decision Medicine™, has announced the launch of oncoReveal® Lymphoid, a ...
IDT and Beckman Coulter Life Sciences' collaboration marks a significant step forward in enabling labs to streamline oncology research workflows with enhanced precision, scalability, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback